# Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

> **NCT07282873** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **TYK Medicines, Inc** · enrollment: 219 (estimated)

## Conditions studied

- Solid Tumor Malignancies
- Malignant Mesothelioma (MM)

## Interventions

- **DRUG:** TYK-01054

## Key facts

- **NCT ID:** NCT07282873
- **Lead sponsor:** TYK Medicines, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-01
- **Final completion:** 2029-06
- **Target enrollment:** 219 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282873, "Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07282873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*